Cartesian Therapeutics Inc (RNAC)

Jun 05, 2025

Nuveen Asset Management LLC Buys 47,889 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

Jun 05, 2025

Jun 04, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants - GlobeNewswire

Jun 04, 2025

Jun 03, 2025

Cartesian Therapeutics Announces New Employment Inducement Grants | RNAC Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Cartesian Therapeutics (RNAC) Issues Inducement Stock Options to New Employees | RNAC Stock News - GuruFocus

Jun 03, 2025

Jun 03, 2025

Cartesian Therapeutics Awards 26,350 Stock Options to Key New Hires in Autoimmune Disease Research - Stock Titan

Jun 03, 2025

Jun 03, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Shares Acquired by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World

Jun 03, 2025

Jun 02, 2025

H.C. Wainwright maintains buy rating on Cartesian Therapeutics stock By Investing.com - Investing.com Nigeria

Jun 02, 2025

Jun 01, 2025

Cartesian Therapeutics Announces First Participant Enrolled in the Phase 3 AURORA Trial of Descartes-08 in Patients with Myasthenia Gravis - Revista ADVFN

Jun 01, 2025

May 30, 2025

Cartesian Therapeutics Enrolls First Participant in Phase 3 Myasthenia Gravis Study - marketscreener.com

May 30, 2025

May 30, 2025

Cartesian Therapeutics Announces First Participant Enrolled - GlobeNewswire

May 30, 2025

May 30, 2025

RNAC Initiates Phase 3 Trial for Myasthenia Gravis Treatment | R - GuruFocus

May 30, 2025

May 30, 2025

RNAC Initiates Phase 3 Trial for Myasthenia Gravis Treatment | RNAC Stock News - GuruFocus

May 30, 2025

May 30, 2025

Cartesian Therapeutics Announces First Participant Enrolled in t - GuruFocus

May 30, 2025

May 30, 2025

Cartesian Therapeutics Initiates Phase 3 AURORA Trial of Descartes-08 for Myasthenia Gravis - Nasdaq

May 30, 2025

May 30, 2025

Revolutionary CAR-T Treatment Enters Phase 3 Trial After Strong Results in Myasthenia Gravis Patients - Stock Titan

May 30, 2025

May 27, 2025

With Trials In Motion, Cash To 2027, Can Kyverna's Next Data Drop Turn The Stock Around? - Benzinga

May 27, 2025

May 27, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Holdings Lifted by Northern Trust Corp - Defense World

May 27, 2025

May 22, 2025

Q1 Earnings Forecast for RNAC Issued By HC Wainwright - Defense World

May 22, 2025

May 22, 2025

HC Wainwright Has Bearish Forecast for RNAC Q2 Earnings - Defense World

May 22, 2025

May 21, 2025

Weyerhaeuser to Sell Princeton, B.C., Lumber Mill to Gorman Group - The Globe and Mail

May 21, 2025

May 20, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World

May 20, 2025

May 19, 2025

Multiple Myeloma Pipeline 2025: Groundbreaking Clinical - openPR.com

May 19, 2025

May 15, 2025

Cantor Fitzgerald Comments on RNAC FY2025 Earnings - Defense World

May 15, 2025

May 13, 2025

Cartesian Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ - The Manila Times

May 13, 2025

May 13, 2025

Cartesian Therapeutics to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor ... - Eagle-Tribune

May 13, 2025

May 13, 2025

Wells Fargo & Company MN Acquires 2,568 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

May 13, 2025

May 12, 2025

Cartesian Therapeutics (RNAC) Poised for Growth with Strong Phas - GuruFocus

May 12, 2025

May 11, 2025

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - Yahoo Finance

May 11, 2025

May 11, 2025

Barclays PLC Buys 7,488 Shares of Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

May 11, 2025

May 10, 2025

MetLife Investment Management LLC Invests $119,000 in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

May 10, 2025

May 10, 2025

Cartesian Therapeutics First Quarter 2025 Earnings: Beats Expectations - Yahoo

May 10, 2025

May 10, 2025

Needham & Company LLC Has Lowered Expectations for Cartesian Therapeutics (NASDAQ:RNAC) Stock Price - Defense World

May 10, 2025

May 09, 2025

Analysts Are Bullish on Top Healthcare Stocks: Harrow Health (HROW), Cartesian Therapeutics (RNAC) - The Globe and Mail

May 09, 2025

May 09, 2025

Cartesian Therapeutics Reports Q1 2025 Financial Results - TipRanks

May 09, 2025

May 08, 2025

Needham Maintains Buy Rating on RNAC, Lowers Price Target | RNAC Stock News - GuruFocus

May 08, 2025

May 08, 2025

RNAC Reports Strong Q1 Revenue Exceeding Expectations | RNAC Stock News - GuruFocus

May 08, 2025

May 08, 2025

Cartesian Therapeutics Inc (RNAC) Q1 2025 Earnings: EPS Loss of $(0.68) Beats Estimate, Revenue Surpasses Forecast at $1.1 Million - GuruFocus

May 08, 2025

May 08, 2025

Cartesian Therapeutics Announces Upcoming Clinical Trials and Positive Results for Descartes-08 in Autoimmune Diseases - Nasdaq

May 08, 2025

May 08, 2025

Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 08, 2025

May 08, 2025

Cartesian Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire Inc.

May 08, 2025

May 06, 2025

Renaissance Technologies LLC Buys New Holdings in Cartesian Therapeutics, Inc. (NASDAQ:RNAC) - Defense World

May 06, 2025

May 05, 2025

Why Cartesian Therapeutics, Inc. (RNAC) is Among the Best Small Cap Stocks to Buy with the Biggest Upside Potential - Insider Monkey

May 05, 2025

May 04, 2025

Subdued Growth No Barrier To Cartesian Therapeutics, Inc. (NASDAQ:RNAC) With Shares Advancing 27% - simplywall.st

May 04, 2025

May 03, 2025

Top 11 Small Cap Stocks to Buy with Biggest Upside Potential - Insider Monkey

May 03, 2025

May 02, 2025

Cartesian Therapeutics (RNAC) Issues Inducement Awards to New Em - GuruFocus

May 02, 2025

May 02, 2025

Cartesian Therapeutics Expands Clinical Team: 27,700 Shares Granted to New Biotech Experts - Stock Titan

May 02, 2025

Apr 29, 2025

Cartesian Therapeutics CTO transitions to consultant role By Investing.com - Investing.com India

Apr 29, 2025

Apr 29, 2025

Cartesian Therapeutics CTO transitions to consultant role - Investing.com

Apr 29, 2025

Apr 29, 2025

Cartesian Therapeutics CTO Transition to Consultant Role - TipRanks

Apr 29, 2025